GSK Plc (GSK)
58.94
+0.40
(+0.68%)
USD |
NYSE |
Feb 13, 16:00
59.17
+0.23
(+0.39%)
After-Hours: 20:00
GSK Free Cash Flow : 5.712B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AstraZeneca PLC | 8.977B |
| Mereo BioPharma Group Plc | -33.02M |
| Biodexa Pharmaceuticals Plc | -14.30M |
| NuCana Plc | -18.19M |
| AnaptysBio, Inc. | -145.42M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.744B |
| Cash from Investing (Quarterly) | -3.184B |
| Cash from Financing (Quarterly) | 1.089B |
| Free Cash Flow Per Share (Quarterly) | 0.6832 |
| Free Cash Flow to Equity (Quarterly) | 1.457B |
| Free Cash Flow to Firm (Quarterly) | 1.587B |
| Free Cash Flow Yield | 4.72% |